34 results
S-3ASR
EX-5.1
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
is, and the Company and each party to the Relevant Agreements will at all relevant times remain, in compliance with all applicable anti-corruption, anti
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
to Autolus, if [***], then [***]. 15.7 Compliance.
55 (a) Compliance with Anti-Corruption Laws. In connection with this Agreement, the Parties shall
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
it is a bellwether program and one we watch closely.
The U.S. Foreign Corrupt Practice Act, the UK Bribery Act 2010 and Other Anti-corruption Laws
The U.S … .
Our operations are also subject to non-U.S. anti-corruption laws such as the UK Bribery Act 2010 (the “UK Bribery Act”). As with the FCPA
8-K
EX-1.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
of the Bribery Act 2010 of the United Kingdom, the Foreign Corrupt Practices Act of 1977, or any other applicable anti-bribery or anti-corruption law;
(hh
8-K
EX-5.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
of the Agreements is and will at all relevant times remain, in compliance with all applicable anti-corruption, anti-money laundering, anti-terrorism
8-K
EX-10.1
2s5g 8jh2evw3mnlt7
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
EX-5.1
27pa0rr76t5 654pv0l
7 Feb 24
Automatic shelf registration
10:00pm
6-K
EX-5.1
sfz e0kpp3ke68l
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K
EX-1.1
bca4wd
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
F-3
EX-5.1
zzq j75eb
3 May 22
Shelf registration (foreign)
7:25pm
F-3
EX-5.1
sz14e6fajovpvu
14 Apr 22
Shelf registration (foreign)
9:30pm
6-K
EX-99.1
28ffxrsgixzetd9
8 Nov 21
Securities Purchase Agreement
5:28pm
F-3
EX-5.1
xfk686tfo59x 62z52
6 Aug 21
Shelf registration (foreign)
2:30pm
6-K
EX-1
2iokib vh
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-5.1
zbyx4a tl
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-1.1
0ggtn7gej3id
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-1.1
zt242m2xy5ms691j369
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am